DK1608336T3 - Formulering til en doseringsinhalator med hydrofluorakaner som drivmidler - Google Patents

Formulering til en doseringsinhalator med hydrofluorakaner som drivmidler

Info

Publication number
DK1608336T3
DK1608336T3 DK04757846T DK04757846T DK1608336T3 DK 1608336 T3 DK1608336 T3 DK 1608336T3 DK 04757846 T DK04757846 T DK 04757846T DK 04757846 T DK04757846 T DK 04757846T DK 1608336 T3 DK1608336 T3 DK 1608336T3
Authority
DK
Denmark
Prior art keywords
formulation
hydrofluoracanes
propellants
dosing inhaler
inhaler
Prior art date
Application number
DK04757846T
Other languages
Danish (da)
English (en)
Inventor
George Destefano
Linda Jean Kelash-Cannavo
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK1608336T3 publication Critical patent/DK1608336T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DK04757846T 2003-03-20 2004-03-19 Formulering til en doseringsinhalator med hydrofluorakaner som drivmidler DK1608336T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45611303P 2003-03-20 2003-03-20
PCT/US2004/008375 WO2004084858A2 (fr) 2003-03-20 2004-03-19 Formulation pour un aerosol-doseur utilisant des hydro-fluoro-alcanes comme propulseurs

Publications (1)

Publication Number Publication Date
DK1608336T3 true DK1608336T3 (da) 2008-06-02

Family

ID=33098086

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04757846T DK1608336T3 (da) 2003-03-20 2004-03-19 Formulering til en doseringsinhalator med hydrofluorakaner som drivmidler

Country Status (28)

Country Link
US (1) US7914770B2 (fr)
EP (1) EP1608336B1 (fr)
JP (1) JP4708332B2 (fr)
KR (1) KR101113003B1 (fr)
CN (1) CN1761455A (fr)
AT (1) ATE390125T1 (fr)
AU (1) AU2004224367B2 (fr)
BR (1) BRPI0408547A (fr)
CA (1) CA2519523C (fr)
CO (1) CO5640070A2 (fr)
CY (1) CY1108137T1 (fr)
DE (1) DE602004012718T2 (fr)
DK (1) DK1608336T3 (fr)
EA (1) EA009087B1 (fr)
EC (1) ECSP056029A (fr)
ES (1) ES2304616T3 (fr)
HR (1) HRP20050822B1 (fr)
ME (1) ME00420B (fr)
MX (1) MXPA05009920A (fr)
NO (1) NO336457B1 (fr)
NZ (1) NZ542957A (fr)
PL (1) PL1608336T3 (fr)
PT (1) PT1608336E (fr)
RS (1) RS51663B (fr)
SI (1) SI1608336T1 (fr)
UA (1) UA89751C2 (fr)
WO (1) WO2004084858A2 (fr)
ZA (1) ZA200506463B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004011381A1 (de) * 2004-03-05 2005-09-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Impaktionsdüse für treibgasbetriebene Dosieraerosole
MXPA06015204A (es) * 2004-07-02 2007-03-15 Boehringer Ingelheim Int Formulaciones en suspension de aerosol con tg 227 ea o tg 134 a como agentes propulsores.
US20060140873A1 (en) * 2004-12-27 2006-06-29 Chang Heng W Aerosol pharmaceutical compositions
GB0501956D0 (en) * 2005-01-31 2005-03-09 Arrow Internat Nebulizer formulation
GB0518769D0 (en) * 2005-09-14 2005-10-19 Medpharm Ltd Topical formulations
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
DE102006014433A1 (de) * 2006-03-27 2007-10-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dosieraerosole für die Verabreichung von pharmazeutischen Zubereitungen
DE102006017320A1 (de) * 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
WO2008047239A2 (fr) * 2006-09-21 2008-04-24 Medispray Laboratories Pvt. Ltd. Formulatons pharmaceutiques en aérosol stables
AU2008289109B2 (en) * 2007-08-17 2012-02-02 Centrexion Therapeutics Corporation High concentration local anesthetic formulations
EP2077132A1 (fr) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif distributeur, dispositif de stockage et procédé pour la distribution d'une formulation
US8119694B2 (en) 2008-08-15 2012-02-21 Arcion Therapeutics, Inc. High concentration local anesthetic formulations
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
EP2432531B1 (fr) 2009-05-18 2019-03-06 Boehringer Ingelheim International GmbH Adaptateur, dispositif d'inhalation et pulvérisateur
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (fr) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nébuliseur
JP5715640B2 (ja) 2009-11-25 2015-05-13 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP2585151B1 (fr) 2010-06-24 2018-04-04 Boehringer Ingelheim International GmbH Nébuliseur
US20120204871A1 (en) * 2011-02-10 2012-08-16 Julio Cesar Vega Stable, non-corrosive formulations for pressurized metered dose inhalers
EP2694220B1 (fr) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Appareil médical pourvu d'un récipient
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (fr) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Pulvérisateur comprenant des moyens de détrompage
CN102798044B (zh) * 2012-08-02 2014-09-10 深圳市华星光电技术有限公司 侧入式背光模组
WO2015018904A1 (fr) 2013-08-09 2015-02-12 Boehringer Ingelheim International Gmbh Nébuliseur
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
ES2954961T3 (es) 2014-05-07 2023-11-27 Boehringer Ingelheim Int Unidad, nebulizador y método
MX2016014399A (es) 2014-05-07 2017-01-20 Boehringer Ingelheim Int Nebulizador.
EP3139984B1 (fr) 2014-05-07 2021-04-28 Boehringer Ingelheim International GmbH Nébuliseur
EP3280393A1 (fr) * 2015-04-10 2018-02-14 3M Innovative Properties Company Formulation et bouteilles aérosol, inhalateurs, et analogues contenant ladite formulation
GB2573297A (en) * 2018-04-30 2019-11-06 Mexichem Fluor Sa De Cv Pharmaceutical composition
US20230271770A1 (en) * 2020-04-21 2023-08-31 Amphastar Pharmaceuticals, Inc. Anti-Viral Pharmaceutical Formulations Administered Via Devices for Lung Targeted Delivery

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405598A (en) * 1976-01-30 1983-09-20 Fisons, Limited Composition for treating asthma
GB8824804D0 (en) * 1988-10-22 1988-11-30 Fisons Plc Device
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5919435A (en) * 1990-11-09 1999-07-06 Glaxo Group Limited Aerosol formulation containing a particulate medicament
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
SK280911B6 (sk) * 1992-12-09 2000-09-12 Boehringer Ingelheim Pharmaceuticals, Inc. Farmaceutický prostriedok
ES2109696T3 (es) * 1993-04-30 1998-01-16 Minnesota Mining & Mfg Configuracion de cierre hermetico para botes de aerosol.
CA2166970C (fr) * 1993-07-15 2000-12-19 Oh-Seung Kwon Garnitures d'etancheite pour bombes aerosols
KR19980703850A (ko) * 1995-04-14 1998-12-05 그레이엄브레레톤 베클로메타손 디프로피오네이트용 계량 흡입기
GB9513084D0 (en) 1995-06-27 1995-08-30 Bespak Plc Dispensing apparatus
SE9701750D0 (sv) * 1997-05-12 1997-05-12 Astra Pharma Prod Inhalation device and method of manufacture thereof
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
GB2326334A (en) 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
ES2193726T3 (es) * 1998-08-04 2003-11-01 Jago Res Ag Formulaciones de aerosol medicinales.
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6261539B1 (en) * 1998-12-10 2001-07-17 Akwete Adjei Medicinal aerosol formulation
US7074388B2 (en) * 1998-12-10 2006-07-11 Kos Life Science, Inc. Water stabilized medicinal aerosol formulation
US20030008369A1 (en) * 1999-03-03 2003-01-09 Board Of Regents, The University Of Texas System Genetic and epigenetic manipulation of ABC transporters and ecto-phosphatases
GB0002798D0 (en) * 2000-02-09 2000-03-29 Glaxo Group Ltd Actuator nozzle for metered dose inhaler
EP1241113A1 (fr) 2001-03-12 2002-09-18 CHIESI FARMACEUTICI S.p.A. Inhalateur avec des moyens pour améliorer la stabilité chimique des solutions d'aerosol médicinales qu'il contient
DE60239806D1 (de) 2001-06-26 2011-06-01 Norton Healthcare Ltd Verbesserter aerosol-regler

Also Published As

Publication number Publication date
DE602004012718D1 (de) 2008-05-08
JP4708332B2 (ja) 2011-06-22
WO2004084858A2 (fr) 2004-10-07
RS51663B (en) 2011-10-31
PT1608336E (pt) 2008-04-21
BRPI0408547A (pt) 2006-03-07
KR101113003B1 (ko) 2012-02-24
NZ542957A (en) 2008-09-26
SI1608336T1 (sl) 2008-08-31
DE602004012718T2 (de) 2009-05-07
PL1608336T3 (pl) 2008-09-30
CA2519523A1 (fr) 2004-10-07
CN1761455A (zh) 2006-04-19
EP1608336A2 (fr) 2005-12-28
EA009087B1 (ru) 2007-10-26
MXPA05009920A (es) 2005-11-04
WO2004084858A3 (fr) 2004-11-04
NO336457B1 (no) 2015-08-31
KR20050111382A (ko) 2005-11-24
JP2006520797A (ja) 2006-09-14
NO20054839L (no) 2005-10-19
AU2004224367A1 (en) 2004-10-07
EA200501363A1 (ru) 2006-04-28
US20040184994A1 (en) 2004-09-23
US7914770B2 (en) 2011-03-29
HRP20050822B1 (hr) 2013-09-30
CA2519523C (fr) 2012-03-13
EP1608336B1 (fr) 2008-03-26
HRP20050822A2 (en) 2006-10-31
ECSP056029A (es) 2006-01-27
CO5640070A2 (es) 2006-05-31
ATE390125T1 (de) 2008-04-15
RS20050705A (en) 2008-04-04
ME00420B (fr) 2011-12-20
ES2304616T3 (es) 2008-10-16
CY1108137T1 (el) 2014-02-12
AU2004224367B2 (en) 2009-10-08
ZA200506463B (en) 2006-04-26
UA89751C2 (ru) 2010-03-10

Similar Documents

Publication Publication Date Title
DK1608336T3 (da) Formulering til en doseringsinhalator med hydrofluorakaner som drivmidler
EA200600620A1 (ru) Набор для ингаляции с ингаляционным порошком, содержащим тиотропий
HRP20070374T3 (en) Formulations comprising ecteinascidin and a disaccharide
HRP20080564T3 (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
BRPI0412320A (pt) uso de um agente modificador de reologia, e composições de revestimento
BRPI0512988A (pt) método para aumentar a meia-vida plasmática de uma molécula, composto, uso do mesmo, e, composição farmacêutica
ECSP045491A (es) Nueva sal formiato de o-desmetil venlafaxina
SE0301653D0 (sv) Novel compounds
BRPI0412310A (pt) uso de um agente controlador de reologia, agente modificador de reologia, concentrados, e, composições com reologia melhorada
UA99250C2 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ
NO20072005L (no) Nye heterocykliske amider
NO20051187L (no) Depotformuleringer bestaende av aktive arylheterocykliske forbindelser i form av en suspensjon
NO20052557D0 (no) Morfolinderivater for bruk som dopamin-agonister i behandling av blant annet seksuell dysfunksjon.
SG151306A1 (en) Novel benzothiazoles and the use thereof as medicaments
EA200501698A1 (ru) Противовспенивающие композиции
ATE284703T1 (de) Kristallmodifikation eines cyclischen depsipeptids mit besserer wirksamkeit
CL2004001579A1 (es) Composicion farmaceutica que comprende un analogo de somatostatina y acido tartarico, donde la composicion tiene el ph regulado entre 4 y 4,5 y el compuesto activo es l ciclo[{4-(nh2-c2h4-nh-cp-o)pro}-phg-dtrp-lys-tyr(4-bzl)-phe]; y su uso para prepa
DE602004013011D1 (de) Haarbehandlungszusammensetzungen
ECSP056231A (es) Fluorbutenos nematicidas que contienen tiazolina
ATE414540T1 (de) Impfstoffe gegen allergien
DE60322077D1 (de) Pulver-überzugsmittelzusammensetzung
SE0702711L (sv) Ny kemisk substans lämplig för användning som mjukgörare i sprängämnes- och drivmedelsblandningar
WO2006047233A3 (fr) Promoteur de pink-1
DK1575559T3 (da) Doseringsaerosoler med lecithin som overfladeaktivt stof
UA3387U (uk) Застосування 2-феніл-3-карбетокси-4-диметиламінометил-5-оксибензофурану гідрохлориду (вінборону) як утеролітичного засобу